JP Morgan Chase
NFH

JP Morgan Chase’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

JP Morgan Chase’s Portfolio NFH Stock Details NFH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-322
Closed -$4K – 7323
2021
Q4 		$4K Buy
+322
New +$3.63K ﹤0.01% 6456
2021
Q1 		– Sell
-55,101
Closed -$474K – 6500
2020
Q4 		$474K Buy
55,101
+5,111
+10% +$44.1K ﹤0.01% 4400
2020
Q3 		$380K Buy
49,990
+8,471
+20% +$69.5K ﹤0.01% 4105
2020
Q2 		$344K Buy
+41,519
New +$337K ﹤0.01% 4019

Other funds holding NFH

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

JP Morgan Chase's NFH Position: Q1 2022 in Review

JP Morgan Chase sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 322 shares — an estimated $4K sold.

JP Morgan Chase first reported a position in NFH in Q2 2020 and held it in 4 quarters. The position peaked at $474K in Q4 2020. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

  • JP Morgan Chase reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • JP Morgan Chase sold 322 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $4K.
  • JP Morgan Chase first reported a position in New Frontier Health Corporation Ordinary Shares in Q2 2020 and held it in 4 quarters.
  • JP Morgan Chase's New Frontier Health Corporation Ordinary Shares position peaked at $474K in Q4 2020.
  • 2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.